Levocarnil 500 Tablet contains Levo-carnitine 500 mg, a naturally occurring amino acid derivative essential for the transport of long-chain fatty acids into the mitochondria for beta-oxidation and energy production. It is primarily indicated for the treatment of primary and secondary carnitine deficiencies, which may arise from genetic disorders, metabolic conditions, or certain chronic diseases such as renal failure, liver disease, and malnutrition. Levocarnil 500 is also utilized as an adjunct therapy in patients with cardiovascular disorders, including ischemic heart disease and heart failure, to improve myocardial energy metabolism and reduce symptoms of fatigue. Additionally, it may be prescribed in cases of peripheral arterial disease and neuromuscular disorders to enhance muscle function and endurance. The tablet is administered orally, with dosage tailored according to the severity of deficiency and clinical response. Common adverse effects are generally mild and may include gastrointestinal disturbances such as nausea, vomiting, and abdominal cramps. Levocarnil 500 should be used cautiously in patients with hypothyroidism or seizure disorders, and it is contraindicated in individuals with known hypersensitivity to Levo-carnitine. Regular monitoring of carnitine levels and clinical status is recommended to optimize therapeutic outcomes.